This is consistent with the fact that 9.6% of primary breast carcinomas are TRPS1-negative [7], and indicates that, even though strong TRPS1 positivity favors the mammary origin of a metastatic tumor, negativity of TRPS1 cannot completely rule out this origin of a cutaneous metastasis. The gene discussed is TRPS1; the disease is metastatic neoplasm.